Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting

Clinical Trial Summary

The patient presents to the ophthalmological emergencies and / or to the internal medicine department. NOIA clinical discovery Patient referred in radiology for brain and visual MRI. The two sequences added by the research (8 minutes) will be added to that of the treatment.

See also
	Status	Clinical Trial	Phase
	Active, not recruiting	`NCT04902365` - Neurofeedback in Visual Snow	N/A

See also

Status

Clinical Trial

Phase

Active, not recruiting

NCT04902365 - Neurofeedback in Visual Snow

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04451265
Study type	Observational
Source	Fondation Ophtalmologique Adolphe de Rothschild
Contact	Amelie YAVCHITZ
Phone	0148036431
Email	ayavchitz@for.paris
Status	Recruiting
Phase
Start date	October 26, 2022
Completion date	March 2028

Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting Anterior Ischemic Optic Neuropathy — DACODAC

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms